Explore Laboratory Technology, Laboratory Stuff and more!

Explore related topics

African medical laboratory Lancet on Tuesday launched cervical cancer screening technology in Kenya to enhance the fight against the disease in East Africa. The…

African medical laboratory Lancet on Tuesday launched cervical cancer screening technology in Kenya to enhance the fight against the disease in East Africa. The…

These nanoparticles created by MIT engineers can act as synthetic biomarkers for disease. The particles (brown) are coated with peptides (blue) that are cleaved by enzymes (green) found at the disease site. The peptides then accumulate in the urine, where they can be detected using mass spectrometry.  Image: Justin H. Lo

These nanoparticles created by MIT engineers can act as synthetic biomarkers for disease. The particles (brown) are coated with peptides (blue) that are cleaved by enzymes (green) found at the disease site. The peptides then accumulate in the urine, where they can be detected using mass spectrometry. Image: Justin H. Lo

Study illuminates role of cancer drug decitabine in repairing damaged cells A Purdue University study sheds light on how cell damage is reversed by the cancer drug decitabine and identifies a potential biomarker that could indicate a patient's stage of cancer and response to treatment.

Study illuminates role of cancer drug decitabine in repairing damaged cells A Purdue University study sheds light on how cell damage is reversed by the cancer drug decitabine and identifies a potential biomarker that could indicate a patient's stage of cancer and response to treatment.

RFID Implants Found to Cause Cancer Tumors linked to cancer in laboratory animals, research reviewed by Associated Press. The evidence is strong enough to convince many researchers that more research is needed before any more human implantation takes place.

RFID Implants Found to Cause Cancer Tumors linked to cancer in laboratory animals, research reviewed by Associated Press. The evidence is strong enough to convince many researchers that more research is needed before any more human implantation takes place.

After Trump issues science gag orders, government scientists begin going rogue, plan march on D.C.  By Jen Hayden   2017/01/25 · 15:36

After Trump issues science gag orders, government scientists begin going rogue, plan march on D.C. By Jen Hayden 2017/01/25 · 15:36

Laboratory-on-a-chip technique simplifies detection of cancer DNA biomarkers http://internetmedicine.com/2016/12/14/53914/  SOURCE  December 2016  (Nanowerk News) Cancer is the second leading cause of death in the U.S. making early reliable diagnosis and treatment a priority for researchers. Genomic biomarkers offer great potential for diagnostics and new forms of treatment such as immunotherapy. Miniaturized lab-on-chip approaches are prime candidates for developing viable diagnostic tests…

Laboratory-on-a-chip technique simplifies detection of cancer DNA biomarkers http://internetmedicine.com/2016/12/14/53914/ SOURCE December 2016 (Nanowerk News) Cancer is the second leading cause of death in the U.S. making early reliable diagnosis and treatment a priority for researchers. Genomic biomarkers offer great potential for diagnostics and new forms of treatment such as immunotherapy. Miniaturized lab-on-chip approaches are prime candidates for developing viable diagnostic tests…

Tshililo Michael Masutha, South Africa’s deputy minister of science and technology, participates in cutting the ribbon during the opening ceremony of  the Cape Town HVTN Immunology Laboratory on Oct. 23, 2013 in Cape Town, South Africa. Photo by Robert Hood, Fred Hutchinson Cancer Research Center.

Tshililo Michael Masutha, South Africa’s deputy minister of science and technology, participates in cutting the ribbon during the opening ceremony of the Cape Town HVTN Immunology Laboratory on Oct. 23, 2013 in Cape Town, South Africa. Photo by Robert Hood, Fred Hutchinson Cancer Research Center.

Chinese scientists have become the first to test out the revolutionary CRISPR-Cas9 gene-editing technology in a human cancer patient.

Chinese scientists have become the first to test out the revolutionary CRISPR-Cas9 gene-editing technology in a human cancer patient.

Pinterest • The world’s catalogue of ideas
Search